Report
EUR 140.00 For Business Accounts Only

Essilor Opportunity

Essilor International S.A. is a French-based international ophthalmic optics company that designs, manufactures and markets lenses to correct or protect eyesight. Its headquarters is based in Charenton-le-Pont (near Paris), France. Essilor is quoted on the Euronext Paris Stock Exchange. It is a component of the Euro Stoxx 50 share index.

Essilor is responsible for creating Varilux, the world's first progressive lens which corrects presbyopia and allows clear vision in the wearer's near, intermediate and far vision. The company formed from the merger of ophthalmic firms Essel and Silor in 1972. Its activities are largely focused on research and development. It is the world's largest manufacturer of ophthalmic lenses.

Underlying
EssilorLuxottica SA

Essilor International (Compagnie Generale d'Optique) designs, manufactures and sells ophthalmic lenses, ophthalmic optical instruments and equipment. Co.'s activities are divided into three segments: Lenses and Optical Instruments (Co. designs, manufactures and customizes corrective lenses such as: Varilux (progressive lenses); anti-reflective, smudge-proof and anti-static lenses (Crizal); Nikon lenses, Transitions variable-tint lenses and Kodak lenses under agreements; polarized lenses (Xperio) and fog-proof lenses (Optifog)), Equipment (Co. produces, distributes and sells equipment and consumables used by prescription laboratories) and Readers (Co. designs and sells reading glasses).

Provider
Ambrosetti Asset Management SIM
Ambrosetti Asset Management SIM

​Since 2003, Ambrosetti Asset Management is a stockbroking company authorized by Governmental Authorities to execute advisory services for investment and wealth management. We are specialized in providing support services to asset management activities (asset selection, asset allocation, market timing, analysis & research) as well as tailor-made solutions and strategies.

Other Reports on these Companies
Other Reports from Ambrosetti Asset Management SIM

ResearchPool Subscriptions

Get the most out of your insights

Get in touch